NP47822 Multiple Sclerosis Medicines

A Contract Award Notice
by THE COMMON SERVICES INDUSTRY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£13M
Sector
HEALTH
Published
15 Feb 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 4 suppliers

1 buyer

4 suppliers

Description

Supply of Multiple Sclerosis Medicines to NHS Scotland

Total Quantity or Scope

Supply of Multiple Sclerosis Medicines to NHS Scotland. The Authority has awarded the Framework Agreement as a multi supplier framework agreement per line to four (4) Framework Participants. The medicines awarded to the Framework Agreement are as follows: - Glatiramer acetate injection - Interferon beta-1a

Award Detail

1 Biogen Idec (Maidenhead)
  • Reference: 004666-2023-1
  • Value: £12,985,684 [share]
  • Awarded to group of suppliers.
2 Merck Serono (Middlesex)
  • Reference: 004666-2023-1
  • Value: £12,985,684 [share]
  • Awarded to group of suppliers.
3 Mylan (Hatfield)
  • Reference: 004666-2023-1
  • Value: £12,985,684 [share]
  • Awarded to group of suppliers.
4 Teva (Castleford)
  • Reference: 004666-2023-1
  • Value: £12,985,684 [share]
  • Awarded to group of suppliers.

Award Criteria

Technical (Supply Chain) 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated values referred to in Section II.1.5 and 11.2.6 covers the twenty-six (26) months' contract duration and the twenty-two (22) months' extension period of the Framework Agreement. For further details of individual lines for the Products awarded to the Framework Agreement, please contact the named person at the head of this Notice. (SC Ref:721538)

Reference

Domains